Early diagnosis of leprosy in spouses. The importance of calling cohabitants

Authors

  • Agustina Litter Moser Francisco J. Muñiz Hospital, City of Buenos Aires, Argentina
  • Julieta Fischer Francisco J. Muñiz Hospital, City of Buenos Aires, Argentina
  • Patricia Fernández Pardal Francisco J. Muñiz Hospital, City of Buenos Aires, Argentina
  • Esteban Maronna Francisco J. Muñiz Hospital, City of Buenos Aires, Argentina
  • Viviana Leiro Francisco J. Muñiz Hospital, City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v31i1.2762

Keywords:

leprosy, Hansen's disease, Mycobacterium leprae, contagion, early diagnostic, prophylaxis, index case, cohabitants, spuses

Abstract

Leprosy is caused by the bacillus Mycobacterium leprae/Mycobacterium lepromatosis. Contagion is through bacilliferous patients, predominantly affecting cohabitants. The pathology may initially be indolent. When a patient is diagnosed with leprosy (or “index case”), the cohabitants are summoned to make an early diagnosis. If skin lesions are present, complementary studies will be performed to arrive at a diagnosis. If these are not evident, post-exposure prophylaxis is instituted with 600 mg of rifampicin in a single dose. Two clinical cases of spousal leprosy are presented in patients who were diagnosed after being summoned for a control of cohabitants.

Author Biographies

Agustina Litter Moser, Francisco J. Muñiz Hospital, City of Buenos Aires, Argentina

Fourth-year attending physician, Dermatology Unit

Julieta Fischer, Francisco J. Muñiz Hospital, City of Buenos Aires, Argentina

Staff Physician, Dermatology Unit

Patricia Fernández Pardal, Francisco J. Muñiz Hospital, City of Buenos Aires, Argentina

Staff Physician, Dermatology Unit

Esteban Maronna, Francisco J. Muñiz Hospital, City of Buenos Aires, Argentina

Pathologist, Dermatology Unit

Viviana Leiro, Francisco J. Muñiz Hospital, City of Buenos Aires, Argentina

Head of Unit, Dermatology Unit

References

I. Eichelmann K, González-González SE, Salas-Alanis JC, Ocampo-Candiani J. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment. Actas Dermosifiliogr. 2013;104: 554-563.

II. World Health Organization. Global leprosy (‎Hansen disease)‎ update, 2023: Elimination of leprosy disease is posible. Time to act! Weekly epidemiological record. 2024. Disponible en: https://www.who.int/publications/i/item/who-wer9937-501-521.

III. Maymone MBC, Laughter M, Venkatesh S, Dacso MM, et ál. Leprosy: clinical aspects and diagnostic techniques. J Am Acad Dermatol. 2020;83:1-14.

IV. Blanco-Córdova CA, Cangas-García T. Lepra: impacto psicosocial. Enferm Glob. 2012.11:287-298. [Consultado: 12 de octubre 2024].

V. World Health Organization. Lepra/enfermedad de Hansen. Seguimiento de contactos y profilaxis posterior a la exposición. Orientación técnica. 2020. Disponible en: https://www.who.int/es/publications/i/item/9789290228073. [Consultado: 12 de junio 2024].

VI. Meléndez E, Fuentes J, Rodríguez G. Lepra conyugal. Rev Salud Pública. 2006;8:24-32.

VII World Health Organization. Directrices para el diagnóstico, tratamiento y prevención de la lepra 2018. Disponible en: https://iris.who.int/bitstream/handle/10665/274127/9789290227007-spa.pdf [Consultado: 12 de junio 2024].

VIII. World Health Organization. Consejo Ejecutivo. Lepra (enfermedad de Hansen). Informe de la Secretaría. 2010. Disponible en: https://apps.who.int/gb/ebwha/pdf_files/EB128/B128_16-sp.pdf. [Consultado: 16 de agosto 2024].

IX. Mehta V, Vasanth V, Balachandran C. Conjugal leprosy: a rarity. Dermatol Online J. 2010;16:15. [Consultado: 5 de mayo 2024].

X. Ministerio de Salud de la Nación. Boletín N° 7: Tuberculosis y lepra en la Argentina 2024. Disponible en: https://www.argentina.gob.ar/sites/default/files/2024/04/boletin_tuberculosis_2024_1642024.pdf. [Consultado: 12 de febrero 2024].

XI. Sociedad Argentina de Dermatología. 25° Campaña nacional de educación y prevención de la lepra 2024. Disponible en: https://sad.org.ar/campana-nacional-de-educacion-y-prevencion-de-la-lepra/.

XII. Brasil. Ministério da Saúde. Secretaria de VigilâncIa em Saúde. Departamento de Vigilância Epidemiológica. Guia de procedimentos técnicos: baciloscopia em hanseníase. Editora do Ministério da Saúde, 2010. Disponible en:

https://bvsms.saude.gov.br/bvs/publicacoes/guia_procedimentos_tecnicos_corticosteroides_hanseniase.pdf. [Consultado: 12 de junio 2024].

XIII. Guerrero MI, Arias MT, Garcés MT, León CI. Developing and using a PCR test to detect subclinical Mycobacterium leprae infection. Rev Panam Salud Publica. 2002;11:228-234.

XIV. Vaquero N, Mussari C, Girard-Bosch MC. Modelo natural de dicotomía TH1-TH2. La enfermedad de Hansen. Rev Argent Dermatol. 2010;91:00-00. [Consultado: 12 de junio 2024].

XV. Ozturk Z, Tatliparmak A. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature. Dermatol Ther. 2017;30:10.

Published

2025-04-04

Issue

Section

Original Articles